Home

Bal Pharma Ltd Quarterly Result

Image

Bal Pharma Ltd

NSE: BALPHARMA

Net Profit - Last Quarter

₹ 0.52 Cr.

Last updated on: Apr 04, 2025

Bal Pharma Ltd Quarterly Results Key Highlights

  • The revenue of Bal Pharma Ltd for the Dec '24 is ₹ 73.66 crore as compare to the Sep '24 revenue of ₹ 73.49 crore.
  • This represent the growth of 0.23%a1# The ebitda of Bal Pharma Ltd for the Dec '24 is ₹ 8.26 crore as compare to the Sep '24 ebitda of ₹ 7.49 crore.
  • This represent the growth of 10.28%a1# The net profit of Bal Pharma Ltd for the Dec '24 is ₹ 0.52 crore as compare to the Sep '24 net profit of ₹ 1.04 crore.
  • This represent the decline of -50%a1#.

Bal Pharma Ltd Quarterly Results Analysis

Market Price of Bal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Apr 2025109.04
02 Apr 202590.87
01 Apr 202589.2
28 Mar 202583.16
27 Mar 202585.83
26 Mar 202588.47
25 Mar 202593.38
24 Mar 202588.82
21 Mar 202589.04
20 Mar 202589.13

Historical Revenue of Bal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bal Pharma Ltd

No data available

* All values are in crore

Bal Pharma Ltd News Hub

Bal Pharma schedules AGM

Bal Pharma announced that the Annual General Meeting (AGM) of the company will be held on 25 Septemb

Read more

16 Aug 24

Bal Pharma consolidated net profit rises 225.00% in the June 2024 quarter

Net profit of Bal Pharma rose 225.00% to Rs 0.26 crore in the quarter ended June 2024 as against Rs

Read more

13 Aug 24

Bal Pharma to convene board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 9 September 2024. Powered

Read more

31 Aug 24

Bal Pharma schedules board meeting

Bal Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2024 Powered

Read more

06 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Bal Pharma Ltd

What key financial metrics are included in Bal Pharma Ltd's quarterly results?

Key financial metrics in Bal Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Bal Pharma Ltd announce its quarterly results?

Bal Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Bal Pharma Ltd's quarterly performance impact its stock price?

Bal Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Bal Pharma Ltd's quarterly results on dividends?

The impact of Bal Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Bal Pharma Ltd's quarterly results?

Yes, Bal Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions